Interaction of sporangiomycin with the bacterial ribosome.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000378:metabolism; D001419:Bacteria / Q000378:metabolism*; D001426:Bacterial Proteins / Q000096:biosynthesis; D001665:Binding Sites; D004269:DNA, Bacterial / Q000096:biosynthesis; D003864:Depression, Chemical; D004926:Escherichia coli / Q000378:metabolism; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010455:Peptides / Q000378:metabolism; D011485:Protein Binding; D012329:RNA, Bacterial / Q000096:biosynthesis; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D013460:Sulfur Isotopes
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D010455:Peptides; D012329:RNA, Bacterial; D013460:Sulfur Isotopes